Benecchi Christopher - Nov 1, 2024 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role: Chief Operating Officer
Signature: Greg Shiferman, attorney in fact for BENECCHI CHRISTOPHER
Stock symbol: SAGE
Transactions as of: Nov 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 11/14/2024, 04:42 PM
Previous filing: Aug 7, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SAGE	Common Stock	Award	$0	+6.25K	+33.81%	$0.00	24.7K	Nov 1, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SAGE	Stock Option (Right to buy)	Award	$0	+12.5K		$0.00	12.5K	Nov 1, 2024	Common Stock	12.5K	$6.05	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of shares of common stock issuable under 6,250 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on November 1, 2025, subject to the Reporting Person's continued service.
F2	The option was granted on November 1, 2024 pursuant to the Plan. The shares underlying the option vest over four years, with 25% of the shares vesting on November 1, 2025, and the remainder vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service.

Content

Consists of shares of common stock issuable under 6,250 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on November 1, 2025, subject to the Reporting Person's continued service.

The option was granted on November 1, 2024 pursuant to the Plan. The shares underlying the option vest over four years, with 25% of the shares vesting on November 1, 2025, and the remainder vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service.